Floatz logo

Osrhsa

Hypoalbuminemia

Healthgen Biotechnology Corp.Phase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Hypoalbuminemia cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
Healthgen Biotechnology Corp.
Phase 3BB
Pentoxiphylline
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 3BB
Alpha Tocopherol
University of Ioannina
N/AD
L-AMINO ACIDS
University of Ioannina
N/AD

Same molecule, other indications

Osrhsa is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →